Treatment of alarming head and neck infantile hemangiomas with interferon-α2a: a clinical study in eleven consecutive patients. [electronic resource]
- Drug design, development and therapy 2015
- 723-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1177-8881
10.2147/DDDT.S67682 doi
Antineoplastic Agents--adverse effects Female Head and Neck Neoplasms--drug therapy Hemangioma--drug therapy Humans Infant Interferon alpha-2 Interferon-alpha--adverse effects Male Recombinant Proteins--adverse effects Time Factors Treatment Outcome Tumor Burden